ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ

ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ
ᱴᱤᱠᱟᱹ ᱨᱮᱭᱟᱜ ᱵᱚᱨᱱᱚᱱ
ᱡᱚᱥ ᱟᱡᱟᱨ	ᱯᱳᱞᱤᱭᱳ
ᱞᱮᱠᱟᱱ	IPV: ᱤᱱ-ᱮᱠᱴᱤᱵᱷᱮᱴᱮᱰ (inactivated); OPV: ᱞᱟᱲᱮᱡ ᱟᱠᱟᱱ (attenuated); nOPV2: ᱞᱟᱲᱮᱡ ᱟᱠᱟᱱ, ᱡᱮᱱᱮᱴᱤᱠ ᱞᱮᱠᱟᱛᱮ ᱛᱷᱟᱯᱚᱱ ᱟᱠᱟᱱ
ᱠᱞᱤᱱᱤᱠᱟᱞ ᱰᱮᱴᱟ
ᱵᱮᱯᱟᱨ ᱧᱩᱛᱩᱢᱠᱚ	Ipol, Poliovax, ᱮᱴᱟᱜ ᱠᱚ
ᱮ.ᱮᱭᱤᱪ.ᱮᱯᱷ.ᱮᱥ/ᱰᱨᱟᱜᱥ.ᱠᱚᱢ	Monograph
ᱢᱮᱰᱞᱟᱭᱤᱱᱯᱞᱟᱥ	a601177
ᱰᱮᱴᱟ	US DailyMed: Ipol;
ᱦᱚᱲᱢᱚᱜ; ᱛᱷᱚᱠ	AU: B2 ;
ᱵᱮᱵᱷᱟᱨ ᱨᱮᱱᱟᱜ; ᱴᱷᱟᱶ	IPV: ᱤᱱᱡᱮᱠᱥᱚᱱ (parenteral); OPV: ᱢᱚᱪᱟ ᱛᱮ (oral)
ᱮ.ᱴᱤ.ᱥᱤ ᱠᱳᱰ	J07BF01 (WHO) ᱪᱷᱟᱸᱪ:ATC ᱪᱷᱟᱸᱪ:ATC ᱪᱷᱟᱸᱪ:ATC;
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ	US: ℞-only ;
ᱩᱯᱨᱩᱢᱤᱭᱟᱹ
ᱥᱤ.ᱮ.ᱮᱥ ᱱᱚᱢᱵᱚᱨ	1008119-78-5;
ᱰᱨᱟᱜᱵᱮᱸᱠ	DB10796; DB10797;
ᱠᱮᱢᱥᱯᱟᱭᱰᱟᱨ	None;
ᱠᱮ.ᱤ.ᱡᱤ.ᱡᱤ	D05543;

ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ ᱫᱚ ᱢᱤᱫ ᱴᱤᱠᱟᱹ ᱠᱟᱱᱟ ᱡᱟᱦᱟᱸ ᱫᱚ ᱯᱳᱞᱤᱭᱳ ᱴᱷᱟᱠᱮᱫ ᱞᱟᱹᱜᱤᱫ ᱵᱮᱵᱷᱟᱨᱚᱜᱼᱟ ᱾^[᱕]^[᱖] ᱱᱚᱣᱟ ᱫᱚ ᱵᱟᱨ ᱞᱮᱠᱟᱱᱟᱜ ᱵᱮᱵᱷᱟᱨᱚᱜᱼᱟ: ᱢᱤᱫᱴᱟᱹᱝ ᱫᱚ ᱤᱱᱡᱮᱠᱥᱚᱱ ᱛᱟᱞᱟ ᱛᱮ ᱮᱢᱚᱜ ᱠᱟᱱ ᱤᱱ-ᱮᱠᱴᱤᱵᱷᱮᱴᱮᱰ ᱴᱤᱠᱟᱹ ᱟᱨ ᱢᱤᱫᱴᱟᱹᱝ ᱫᱚ ᱢᱚᱪᱟ ᱛᱮ ᱮᱢᱚᱜ ᱠᱟᱱ ᱞᱟᱲᱮᱡ ᱟᱠᱟᱱ ᱯᱳᱞᱤᱭᱳ ᱵᱷᱟᱭᱨᱟᱥ ᱾^[᱕] ᱡᱮᱜᱮᱛ ᱦᱚᱲᱢᱚ ᱥᱟᱶᱟᱨ ᱜᱟᱶᱛᱟ ᱫᱚ ᱥᱟᱱᱟᱢ ᱜᱤᱫᱽᱨᱟᱹ ᱜᱮ ᱯᱳᱞᱤᱭᱳ ᱵᱤᱨᱩᱫᱽ ᱨᱮ ᱯᱩᱨᱟᱹ ᱴᱤᱠᱟᱹ ᱦᱟᱛᱟᱣ ᱞᱟᱹᱜᱤᱫ ᱮ ᱢᱮᱱᱟ ᱾^[᱕] ᱱᱚᱣᱟ ᱵᱟᱱᱟᱨ ᱴᱤᱠᱟᱹ ᱛᱮ ᱜᱮ ᱡᱮᱜᱮᱛ ᱨᱮᱱᱟᱜ ᱟᱭᱢᱟ ᱴᱚᱴᱷᱟ ᱠᱷᱚᱱ ᱯᱳᱞᱤᱭᱳ ᱪᱟᱵᱟ ᱟᱠᱟᱱᱟ,^[᱗]^[᱘] ᱟᱨ ᱥᱮᱨᱢᱟᱠᱤᱭᱟᱹ ᱨᱤᱯᱳᱨᱴ ᱟᱠᱟᱱ ᱠᱮᱥ ᱨᱮᱱᱟᱜ ᱞᱮᱠᱷᱟ ᱫᱚ ᱑᱙᱘᱘ ᱨᱮ ᱓᱕᱐,᱐᱐᱐ ᱠᱷᱚᱱ ᱒᱐᱑᱘ ᱨᱮ ᱓᱓ ᱨᱮ ᱠᱚᱢ ᱟᱠᱟᱱᱟ ᱾^[᱙]^[᱑᱐]

ᱤᱱ-ᱮᱠᱴᱤᱵᱷᱮᱴᱮᱰ ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ ᱠᱚᱫᱚ ᱟᱹᱰᱤ ᱜᱮ ᱱᱟᱯᱟᱭᱟ ᱾^[᱕] ᱤᱱᱡᱮᱠᱥᱚᱱ ᱮᱢ ᱟᱠᱟᱱ ᱴᱷᱟᱶ ᱨᱮ ᱠᱟᱹᱴᱤᱡ ᱟᱨᱟᱜ ᱦᱩᱭ ᱫᱟᱲᱮᱭᱟᱜᱼᱟ ᱟᱨᱵᱟᱝ ᱦᱟᱹᱥᱩ ᱦᱩᱭ ᱫᱟᱲᱮᱭᱟᱜᱼᱟ ᱾^[᱕] ᱢᱚᱪᱟ ᱛᱮ ᱮᱢᱚᱜ ᱠᱟᱱ ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ ᱠᱷᱟᱹᱛᱤᱨ ᱜᱮᱥᱟᱭ-ᱜᱮᱥᱟᱭ ᱰᱳᱡᱽ ᱢᱩᱫᱽ ᱨᱮ ᱟᱹᱰᱤ ᱠᱚᱢ ᱦᱚᱲ ᱜᱮ ᱴᱤᱠᱟᱹ-ᱡᱚᱲᱟᱣ ᱯᱟᱨᱟᱞᱟᱭᱴᱤᱠ ᱯᱳᱞᱤᱭᱳ ᱦᱩᱭ ᱫᱟᱲᱮᱭᱟᱠᱚᱣᱟ ᱾^[᱕] ᱱᱚᱣᱟ ᱫᱚ ᱯᱳᱞᱤᱭᱳ ᱤᱱᱯᱷᱮᱠᱥᱚᱱ ᱛᱟᱭᱚᱢ ᱯᱟᱨᱟᱞᱟᱭᱤᱥ ᱦᱩᱭᱩᱜ ᱠᱟᱱ ᱕,᱐᱐᱐ ᱠᱮᱥ ᱛᱩᱞᱟᱹᱡᱚᱠᱷᱟ ᱨᱮ ᱟᱹᱰᱤ ᱜᱮ ᱠᱚᱢᱟ ᱾^[᱑᱑] ᱵᱟᱱᱟᱨ ᱞᱮᱠᱟᱱ ᱴᱤᱠᱟᱹ ᱜᱮ ᱜᱚᱲᱦᱚᱱ ᱦᱚᱲ ᱟᱨ HIV/AIDS ᱢᱮᱱᱟᱜ ᱠᱚ ᱦᱚᱲ ᱞᱟᱹᱜᱤᱫ ᱥᱟᱫᱷᱟᱨᱚᱱ ᱞᱮᱠᱟᱛᱮ ᱱᱟᱯᱟᱭ ᱜᱮᱭᱟ ᱾^[᱕] ᱮᱱᱛᱮ ᱨᱮᱦᱚᱸ, ᱴᱤᱠᱟᱹ-ᱠᱷᱚᱱ ᱚᱢᱚᱱ ᱟᱠᱟᱱ ᱯᱳᱞᱤᱭᱳ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮᱱᱟᱜ ᱵᱚᱛᱚᱨ ᱠᱷᱟᱹᱛᱤᱨ ᱱᱟᱶᱟ ᱳᱨᱟᱞ ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ ᱴᱟᱭᱤᱯ ᱒ ᱵᱮᱱᱟᱣ ᱟᱠᱟᱱᱟ, ᱡᱟᱦᱟᱸ ᱨᱮᱱᱟᱜ ᱡᱚᱥ ᱫᱚ ᱴᱤᱠᱟᱹ ᱟᱨᱦᱚᱸ ᱥᱩᱨᱚᱠᱷᱤᱛ ᱵᱮᱱᱟᱣ ᱠᱟᱱᱟ ᱾^[᱑᱒]

ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ ᱨᱮᱱᱟᱜ ᱯᱩᱭᱞᱩ ᱥᱟᱹᱛ ᱩᱫᱩᱜ ᱫᱚ ᱑᱙᱕᱐ ᱨᱮ ᱦᱤᱞᱟᱨᱤ ᱠᱚᱯᱨᱳᱣᱥᱠᱤ ᱦᱚᱛᱮᱛᱮ ᱦᱩᱭ ᱞᱮᱱᱟ, ᱡᱟᱦᱟᱸ ᱫᱚ ᱢᱤᱫ ᱡᱤᱣᱤᱫ ᱞᱟᱲᱮᱡ ᱟᱠᱟᱱ ᱵᱷᱟᱭᱨᱟᱥ ᱛᱟᱦᱮᱸ ᱠᱟᱱᱟ ᱾^[᱑᱓] ᱱᱚᱣᱟ ᱴᱤᱠᱟᱹ ᱫᱚ ᱟᱢᱮᱨᱤᱠᱟ ᱨᱮ ᱵᱮᱵᱷᱟᱨ ᱞᱟᱹᱜᱤᱫ ᱢᱟᱹᱱ ᱵᱟᱭ ᱧᱟᱢ ᱞᱮᱫᱼᱟ, ᱢᱮᱱᱠᱷᱟᱱ ᱮᱴᱟᱜ ᱴᱷᱟᱶ ᱨᱮ ᱱᱚᱣᱟ ᱨᱮᱱᱟᱜ ᱵᱮᱵᱷᱟᱨ ᱥᱟᱹᱛ ᱞᱮᱱᱟ ᱾^[᱑᱓] ᱡᱳᱱᱟᱥ ᱥᱟᱞᱠ ᱦᱚᱛᱮᱛᱮ ᱵᱮᱱᱟᱣ ᱟᱠᱟᱱ ᱤᱱ-ᱮᱠᱴᱤᱵᱷᱮᱴᱮᱰ (ᱜᱚᱡ ᱟᱠᱟᱱ) ᱯᱳᱞᱤᱭᱳ ᱴᱤᱠᱟᱹ ᱨᱮᱱᱟᱜ ᱡᱤᱛᱠᱟᱹᱨ ᱫᱚ ᱑᱙᱕᱕ ᱨᱮ ᱞᱟᱹᱭ ᱥᱚᱫᱚᱨ ᱞᱮᱱᱟ ᱾^[᱕]^[᱑᱔] ᱟᱨ ᱢᱤᱫᱴᱟᱹᱝ ᱢᱚᱪᱟ ᱛᱮ ᱮᱢᱚᱜ ᱠᱟᱱ ᱴᱤᱠᱟᱹ ᱫᱚ ᱟᱞᱵᱟᱨᱴ ᱥᱟᱵᱤᱱ ᱦᱚᱛᱮᱛᱮ ᱵᱮᱱᱟᱣ ᱞᱮᱱᱟ ᱟᱨ ᱑᱙᱖᱑ ᱨᱮ ᱵᱮᱯᱟᱨᱤ ᱞᱮᱠᱟᱛᱮ ᱵᱮᱵᱷᱟᱨ ᱮᱛᱚᱦᱚᱵ ᱞᱮᱱᱟ ᱾^[᱕]^[᱑᱕]^[᱑᱖]

ᱥᱟᱹᱠᱷᱭᱟᱹᱛ

↑ Use During Pregnancy and Breastfeeding
↑ "Ipol (poliovirus type 1 antigen) (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen- formaldehyde inactivated injection, suspension". DailyMed. 2 April 2025. Retrieved 8 November 2025.
↑ "Ipol – Poliovirus Vaccine Inactivated (Monkey Kidney Cell)". U.S. Food and Drug Administration (FDA). 11 December 2019. STN: 103930. Archived from the original on 23 December 2019.
↑ "Routine Polio Vaccination". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2018. Retrieved 8 November 2025.
1 2 3 4 5 6 7 8 9 "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record. 91 (12): 145–68. 2016. hdl:10665/254399. PMID 27039410.
↑ "Polio vaccines: WHO position paper – June 2022". Weekly Epidemiological Record. 97 (25): 277–300. 2022. hdl:10665/357168.
↑ Aylward RB (2006). "Eradicating polio: today's challenges and tomorrow's legacy". Annals of Tropical Medicine and Parasitology. 100 (5–6): 401–413. doi:10.1179/136485906X97354. PMID 16899145. S2CID 25327986.
↑ Schonberger LB, Kaplan J, Kim-Farley R, Moore M, Eddins DL, Hatch M (1984). "Control of paralytic poliomyelitis in the United States". Reviews of Infectious Diseases. 6 (Suppl 2): S424–S426. doi:10.1093/clinids/6.Supplement_2.S424. PMID 6740085.
↑ "Global Wild Poliovirus 2014–2019" (PDF). Archived (PDF) from the original on 3 February 2019. Retrieved 3 February 2019.
↑ "Does polio still exist? Is it curable?". World Health Organization (WHO). Archived from the original on 29 May 2018. Retrieved 21 May 2018.
↑ "Poliomyelitis". World Health Organization (WHO). Archived from the original on 18 April 2017. Retrieved 25 April 2017.
↑ "GPEI-nOPV2". Archived from the original on 27 July 2021. Retrieved 1 August 2021.
1 2 Fox M (20 April 2013). "Hilary Koprowski, Who Developed First Live-Virus Polio Vaccine, Dies at 96". The New York Times. Archived from the original on 25 August 2017. Retrieved 8 September 2017.
↑ Bazin H (2011). Vaccination: A History. John Libbey Eurotext. p. 395. ISBN 978-2-7420-0775-2. Archived from the original on 8 September 2017.
↑ Smith DR, Leggat PA (2005). "Pioneering figures in medicine: Albert Bruce Sabin – inventor of the oral polio vaccine". The Kurume Medical Journal. 52 (3): 111–116. doi:10.2739/kurumemedj.52.111. PMID 16422178.
↑ The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list. Geneva: World Health Organization. 2025. doi:10.2471/B09474. hdl:10665/382243. License: CC BY-NC-SA 3.0 IGO.

ᱵᱟᱦᱨᱮ ᱡᱚᱱᱚᱲ

"Polio Vaccine Information Statement". U.S. Centers for Disease Control and Prevention (CDC). 24 July 2025.
'People and Discoveries: Salk Produces Polio Vaccine 1952' Public Broadcasting Service (PBS)

[Drugs.com_pregnancy-1] Use During Pregnancy and Breastfeeding

[2] "Ipol (poliovirus type 1 antigen) (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen- formaldehyde inactivated injection, suspension". DailyMed. 2 April 2025. Retrieved 8 November 2025.

[3] "Ipol – Poliovirus Vaccine Inactivated (Monkey Kidney Cell)". U.S. Food and Drug Administration (FDA). 11 December 2019. STN: 103930. Archived from the original on 23 December 2019.

[4] "Routine Polio Vaccination". U.S. Centers for Disease Control and Prevention (CDC). 11 May 2018. Retrieved 8 November 2025.

[WHO2016-5] 1 2 3 4 5 6 7 8 9 "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record. 91 (12): 145–68. 2016. hdl:10665/254399. PMID 27039410.

[WHO2022-6] "Polio vaccines: WHO position paper – June 2022". Weekly Epidemiological Record. 97 (25): 277–300. 2022. hdl:10665/357168.

[Aylward_2006-7] Aylward RB (2006). "Eradicating polio: today's challenges and tomorrow's legacy". Annals of Tropical Medicine and Parasitology. 100 (5–6): 401–413. doi:10.1179/136485906X97354. PMID 16899145. S2CID 25327986.

[8] Schonberger LB, Kaplan J, Kim-Farley R, Moore M, Eddins DL, Hatch M (1984). "Control of paralytic poliomyelitis in the United States". Reviews of Infectious Diseases. 6 (Suppl 2): S424–S426. doi:10.1093/clinids/6.Supplement_2.S424. PMID 6740085.

[gwp2013-9] "Global Wild Poliovirus 2014–2019" (PDF). Archived (PDF) from the original on 3 February 2019. Retrieved 3 February 2019.

[10] "Does polio still exist? Is it curable?". World Health Organization (WHO). Archived from the original on 29 May 2018. Retrieved 21 May 2018.

[WHO2017Fs114-11] "Poliomyelitis". World Health Organization (WHO). Archived from the original on 18 April 2017. Retrieved 25 April 2017.

[GPEI-nOPV2-12] "GPEI-nOPV2". Archived from the original on 27 July 2021. Retrieved 1 August 2021.

[Kowproski_obit-13] 1 2 Fox M (20 April 2013). "Hilary Koprowski, Who Developed First Live-Virus Polio Vaccine, Dies at 96". The New York Times. Archived from the original on 25 August 2017. Retrieved 8 September 2017.

[14] Bazin H (2011). Vaccination: A History. John Libbey Eurotext. p. 395. ISBN 978-2-7420-0775-2. Archived from the original on 8 September 2017.

[15] Smith DR, Leggat PA (2005). "Pioneering figures in medicine: Albert Bruce Sabin – inventor of the oral polio vaccine". The Kurume Medical Journal. 52 (3): 111–116. doi:10.2739/kurumemedj.52.111. PMID 16422178.

[WHO24th-16] The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list. Geneva: World Health Organization. 2025. doi:10.2471/B09474. hdl:10665/382243. License: CC BY-NC-SA 3.0 IGO.

[᱑]

[᱒]

[᱓]

[᱔]

[᱕]

[᱖]

[᱗]

[᱘]

[᱙]

[᱑᱐]

[᱑᱑]

[᱑᱒]

[᱑᱓]

[᱑᱔]

[᱑᱕]

[᱑᱖]